From: Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage
 | Overall (N = 102) | Ambulatory (N = 76) | Hospitalized (N = 26) | p-value |
---|---|---|---|---|
Age, mean (SD) | 52.21 (14.83) | 50.41 (14.52) | 57.46 (14.72) | 0.04 |
Education in years, mean (SD) | 15.78 (2.45) | 16.06 (2.37) | 14.96 (2.53) | 0.06 |
Sex, n (%) | Â | 0.49 | ||
 Males | 44 (43%) | 31 (41%) | 13 (50%) |  |
 Females | 58 (57%) | 45 (59%) | 13 (50%) |  |
Race, n (%) | Â | 0.03 | ||
 Native American | 0 (0%) | 0 (0%) | 0 (0%) |  |
 Asian | 5 (5%) | 2 (3%) | 3 (12%) |  |
 Native Hawaiian | 0 (0%) | 0 (0%) | 0 (0%) |  |
 Black | 9 (9%) | 4 (5%) | 5 (19%) |  |
 White | 87 (85%) | 69 (91%) | 18 (69%) |  |
 More than one race | 1 (1%) | 1 (1%) | 0 (0%) |  |
Ethnicity, n (%) | Â | 0.2 | ||
 Hispanic | 8 (8%) | 4 (5%) | 4 (15%) |  |
 Non-Hispanic | 94 (92%) | 72 (95%) | 22 (85%) |  |
The COVID-19 Risk Calculation Score (CRC), n (%) |  < 0.044 | |||
 0–2 Points: Low Risk | 69 (68%) | 56 (74%) | 13 (50%) |  |
 3–5 Points: Medium Risk | 30 (29%) | 19 (25%) | 11 (42%) |  |
  >  = 6 Points: High Risk | 3 (3%) | 1 (1.3%) | 2 (8%) |  |
Elixhauser-van Walraven Comorbidity Index (EVCI), mean (SD) | 4.60 (7.62) | 2.39 (6.35) | 11.04 (7.49) |  < 0.001 |
COVID-19 Severity, n (%) |  |  < 0.001 | ||
 Asymptomatic | 11 (11%) | 11 (15%) | 0 (0%) |  |
 Mild – No Hypoxia | 67 (65%) | 65 (85%) | 2 (8%) |  |
 Moderate—Pneumonia | 4 (4%) | 0 (0%) | 4 (15%) |  |
 Severe—Pneumonia | 17 (17%) | 0 (0%) | 17 (65%) |  |
 Critical—ARDS | 3 (3%) | 0 (0%) | 3 (12%) |  |
 Critical—Sepsis | 0 (0%) | 0 (0%) | 0 (0%) |  |
Comorbid Hypertension, n (%) | Â | 0.002 | ||
 no | 66 (67%) | 55 (75%) | 11 (42%) |  |
 yes | 33 (33%) | 18 (25%) | 15 (58%) |  |
Comorbid Coronary Artery Disease, n (%) | 0.015 | |||
 no | 86 (87%) | 67 (92%) | 19 (73%) |  |
 yes | 13 (13%) | 6 (8%) | 7 (27%) |  |
Comorbid Diabetes, n (%) | 0.011 | |||
 no | 89 (90%) | 69 (95%) | 20 (77%) |  |
 yes | 10 (10%) | 4 (5%) | 6 (23%) |  |
Comorbid Obesity, n (%) | Â | Â | Â | 0.046 |
 no | 87 (88%) | 67 (92%) | 20 (77%) |  |
 yes | 12 (12%) | 6 (8%) | 6 (23%) |  |
Comorbid Chronic Neurologic Disease, n (%) | 0.953 | |||
 no | 95 (96%) | 70 (96%) | 25 (96%) |  |
 yes | 4 (4%) | 3 (4%) | 1 (4%) |  |
Comorbid Chronic Psychiatric Disease, n (%) | 0.309 | |||
 no | 73 (73%) | 56 (76%) | 17 (65%) |  |
 yes | 27 (27%) | 18 (24%) | 9 (35%) |  |
Smoking History, n (%) | Â | Â | Â | 0.04 |
 Never Smoked | 72 (71%) | 57 (75%) | 15 (58%) |  |
 Past or Current Smoker | 26 (25%) | 15 (20%) | 11 (42%) |  |
 Unknown/Refused | 4 (4%) | 4 (5%) | 0 (0%) |  |